Skip to content

Clinical trials

Phase 3 Glomerulonephritis, IGA trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Phase: Phase 3 Country / region: Spain Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20183
20202
20212
20221
20232
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting6
Recruiting5
Completed4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Alexion Pharmaceuticals, Inc.2
Calliditas Therapeutics AB2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Biogen1
Hoffmann-La Roche1
Omeros Corporation1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Travere Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA16
Renal Insufficiency, Chronic7
Glomerulonephritis6
Kidney Diseases4
Proteinuria4
Urologic Diseases4
Autoimmune Diseases1
Female Urogenital Diseases1
Female Urogenital Diseases and Pregnancy Complications1
IgA Vasculitis1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.